Pages that link to "Q53351474"
Jump to navigation
Jump to search
The following pages link to Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost (Q53351474):
Displaying 37 items.
- Changes in practice patterns affecting in-hospital and post-discharge survival among ACS patients (Q28201034) (← links)
- Percutaneous coronary intervention: recommendations for good practice and training (Q30479477) (← links)
- Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators. (Q31942397) (← links)
- Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators (Q32076921) (← links)
- Treatment of non-ST-segment-elevation acute coronary syndromes with platelet glycoprotein IIb/IIIa inhibitors: an emergency department perspective (Q33641463) (← links)
- Acute coronary syndromes: interventions. (Q33664183) (← links)
- Early use of coronary angiography and intervention (Q33671954) (← links)
- Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarction. (Q33735570) (← links)
- Diagnosis and management of patients with unstable angina (Q33781183) (← links)
- Analysis of number needed to treat and cost of platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary interventions and acute coronary syndromes (Q33803432) (← links)
- Newer antithrombotic strategies in the initial management of non-ST-segment elevation acute coronary syndromes (Q33838920) (← links)
- Redefining medical treatment in the management of unstable angina (Q34074021) (← links)
- Exploring new strategies for the management of acute coronary syndromes (Q34084224) (← links)
- Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines. (Q34445660) (← links)
- The vulnerable plaque and acute coronary syndromes (Q35035390) (← links)
- Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST–segment elevation myocardial infarction: Appropriate interpretation of the guidelines (Q35562136) (← links)
- Risk stratification of acute coronary syndrome patients. A multi-marker approach (Q36236495) (← links)
- Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm (Q36519924) (← links)
- The NVVC working group guidelines for the management of patients with non-ST-elevation acute coronary syndromes (Q36817207) (← links)
- Biochemical Markers of Myocardial Damage (Q37155174) (← links)
- The effect of place of residence on access to invasive cardiac services following acute myocardial infarction. (Q37252863) (← links)
- Management Strategy in Non-Limb-Threatening Acute Ischaemia of Limbs: Should We Rethink? (Q37397038) (← links)
- Unstable Angina (Q40737172) (← links)
- The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina. (Q40795552) (← links)
- Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy). (Q44397625) (← links)
- Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems (Q44656194) (← links)
- Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome. (Q50141173) (← links)
- Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only (Q51132112) (← links)
- Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes: the potential role of early percutaneous revascularization (Q73218056) (← links)
- Is ST segment elevation non-Q-wave myocardial infarction after thrombolytic therapy a new clinical entity that requires an invasive management strategy? (Q73386889) (← links)
- Optimal management of non-ST segment elevation myocardial infarction remains unclear (Q73583530) (← links)
- "Watchful waiting" after thrombolysis: it's time for a re-evaluation (Q73632567) (← links)
- Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy) (Q78039337) (← links)
- 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial (Q78251271) (← links)
- [Coverage of pointed acute coronary syndromes in the general hospital centers] (Q78755645) (← links)
- [Interventional therapy of acute myocardial infarction] (Q81721527) (← links)
- Early and Long-Term Outcomes After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Disease With Drug-Eluting Stents in Patients With Non-ST–Elevation Acute Coronary Syndrome (Q84851108) (← links)